GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine.
<h4>Background</h4>The injectable glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drugs are commonly used for weight loss among reproductive-aged women but the perception of their impact on fertility is not clear among the public.<h4>Objectives</h4>The purpose of this r...
Saved in:
| Main Authors: | Zaher Merhi, Manasi Karekar, Marco Mouanness |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0326210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01) -
Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01) -
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
by: Ioannis Ilias, et al.
Published: (2025-01-01) -
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
by: Ahmad Moolla, et al.
Published: (2025-05-01) -
Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)